Risk factors
Autonomix Medical (AMIX) risk factors
Item 1A of every Autonomix Medical, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors51 risks1 new9 dropped5 reworded
Going-concern metrics worsened: accumulated deficit reached $67.1 million, operating cash burn $12.3 million, and working capital fell to $5.9 million.
Filed May 27, 2026 - FY2025 10-K risk factors59 risks
Autonomix Medical faces going concern doubts with a $50.4 million accumulated deficit and reliance on a single manufacturer. The company has no approved products, no commercial revenue, and requires additional capital to fund clinical trials. Operations depend heavily on securing FDA clearances, third-party reimbursement codes, and protecting proprietary sensing and ablation technologies.
Filed May 29, 2025